Lifevantage (NASDAQ:LFVN) Director Buys $47,565.00 in Stock

Lifevantage Corporation (NASDAQ:LFVN) Director Judd Dayton bought 10,500 shares of Lifevantage stock in a transaction dated Monday, March 2nd. The stock was purchased at an average cost of $4.53 per share, for a total transaction of $47,565.00. Following the completion of the acquisition, the director directly owned 80,359 shares of the company’s stock, valued at approximately $364,026.27. The trade was a 15.03% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Judd Dayton also recently made the following trade(s):

• On Friday, February 27th, Judd Dayton bought 18,097 shares of Lifevantage stock. The stock was purchased at an average price of $4.63 per share, for a total transaction of $83,789.11.
• On Thursday, February 26th, Judd Dayton purchased 4,600 shares of Lifevantage stock. The shares were purchased at an average price of $4.58 per share, with a total value of $21,068.00.

Lifevantage Price Performance

NASDAQ:LFVN opened at $4.91 on Thursday. The company has a market cap of $62.81 million, a price-to-earnings ratio of 8.18 and a beta of 0.35. Lifevantage Corporation has a 1 year low of $3.90 and a 1 year high of $17.64. The stock’s 50 day simple moving average is $5.56 and its two-hundred day simple moving average is $7.78.

Lifevantage (NASDAQ:LFVN) last posted its earnings results on Wednesday, February 4th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.07). Lifevantage had a net margin of 3.74% and a return on equity of 29.59%. The firm had revenue of $48.93 million for the quarter, compared to the consensus estimate of $54.40 million. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date of this dividend is Monday, March 2nd. Lifevantage’s dividend payout ratio (DPR) is presently 30.00%.

Wall Street Analyst Weigh In

A number of research analysts recently commented on LFVN shares. Wall Street Zen downgraded shares of Lifevantage from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Weiss Ratings restated a “hold (c)” rating on shares of Lifevantage in a research report on Monday, December 29th. Loop Capital set a $5.00 target price on Lifevantage in a report on Thursday, February 5th. Finally, Lake Street Capital reissued a “buy” rating on shares of Lifevantage in a research report on Thursday, February 5th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $5.00.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Capital Management Corp VA lifted its stake in shares of Lifevantage by 3.4% during the 4th quarter. Capital Management Corp VA now owns 2,134,574 shares of the company’s stock worth $13,149,000 after acquiring an additional 70,398 shares during the last quarter. Renaissance Technologies LLC grew its position in Lifevantage by 8.3% in the 4th quarter. Renaissance Technologies LLC now owns 922,918 shares of the company’s stock valued at $5,685,000 after acquiring an additional 70,900 shares during the last quarter. Wasatch Advisors LP increased its stake in Lifevantage by 6.6% in the second quarter. Wasatch Advisors LP now owns 446,341 shares of the company’s stock worth $5,838,000 after purchasing an additional 27,765 shares during the period. Geode Capital Management LLC lifted its position in shares of Lifevantage by 106.1% during the second quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after purchasing an additional 126,274 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its stake in shares of Lifevantage by 305.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 200,222 shares of the company’s stock valued at $1,233,000 after purchasing an additional 150,785 shares during the period. Hedge funds and other institutional investors own 35.32% of the company’s stock.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.